First Trust NYSE Arca Biotechnology Index Fund (FBT) Dividend Yield, History & Forecast

First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. The most recent ex-dividend date was December 13, 2024, with payment scheduled for December 31, 2024. market capitalization is approximately $1.68B.

FBT fund composition

FBT holds 30 positions, with 36.5% of assets in its ten largest. It charges an expense ratio of 0.55%, and manages $3.09B.

Top 10 holdings

HoldingWeight
GMABGenmab A/S (ADR)4.90%
HALOHalozyme Therapeutics, Inc.3.73%
ALKSAlkermes Plc3.53%
VCYTVeracyte, Inc.3.53%
EXELExelixis, Inc.3.51%
NEONeoGenomics, Inc.3.49%
ADMAADMA Biologics, Inc.3.45%
AMGNAmgen Inc.3.45%
REGNRegeneron Pharmaceuticals, Inc.3.45%
ARGXargenx SE (ADR)3.43%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about First Trust NYSE Arca Biotechnology Index Fund (FBT)

When does First Trust NYSE Arca Biotechnology Index Fund pay distributions?
The most recent ex-dividend date was December 13, 2024. The next scheduled dividend payment date is December 31, 2024.
What does First Trust NYSE Arca Biotechnology Index Fund invest in?
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.